AMANDA BURKE: Open Payments
NPI 1982071353 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 7 payments from 6 companies in 2025. Trend: 2023 $599 · 2024 $712 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $147 |
| Organon LLC | 1 | $138 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Edwards Lifesciences Corporation | 1 | $125 |
| Novo Nordisk Inc | 1 | $123 |
| ABBVIE INC. | 2 | $52 |
Products named: REZDIFFRA, VTAMA, STRENSIQ, Wegovy, EPKINLY.
Industry payments across LA — which companies pay providers there.
